Articles: coronavirus.
Showing all 5,186 articles tagged:
Coronavirus
-
Wong briefly summarises COVID pharmaceutical therapies that are currently in trial, and importantly have received media attention.
Highlighting that off-label use of these drugs may be important causes of future toxicological presentations to emergency departments, especially for those widely used in the community for other indications (eg. Plaquenil, Kaletra, colchicine...).
Briefly discussed are:
- Chloroquine/hydroxychloroquine
- Azithromycin
- Kaletra (Lopinavir/ritonavir)
- Colchicine
- Ivermectin
- Tocilizumab
- Thaildomide
- Remdesivir